Repligen | RGEN - EPS Earnings Per Share

Stock Price
150.74
Daily Change
1.37 0.92%
Monthly
-11.04%
Yearly
-5.71%
Q1 Forecast
144.77

Repligen reported $0.46 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 0.44 0.44 Feb/25 2026
FY2025Q3 Sep/2025 0.46 0.42 0.43 Oct/28 2025
FY2025Q2 Jun/2025 0.37 0.39 0.33 Jul/29 2025
FY2025Q1 Mar/2025 0.39 0.35 0.28 Apr/29 2025
FY2024Q4 Dec/2024 0.44 0.41 0.33 Feb/20 2025




Eps Change Date
Agilent USD 1.67 0.37 Sep/2025
Align Technology USD 2.61 0.12 Sep/2025
Bio Techne USD 0.42 0.11 Sep/2025
BioMarin Pharmaceutical USD 0.12 1.32 Sep/2025
Bristol-Myers Squibb USD 1.63 0.17 Sep/2025
Bruker USD 0.45 0.13 Sep/2025
Charles River Laboratories USD 2.43 0.69 Sep/2025
Danaher USD 2.23 0.34 Dec/2025
Dentsply International USD 0.5 0.02 Sep/2025
Exact Sciences USD 0.24 0.25 Sep/2025
General Electric Aerospace USD 1.57 0.09 Dec/2025
Henry Schein USD 1.38 0.28 Sep/2025
Illumina USD 1.34 0.15 Sep/2025
IQVIA Holdings USD 3 0.19 Sep/2025
Mettler Toledo International USD 11.15 1.06 Sep/2025
Myriad Genetics USD 0.05 0.08 Jun/2025
Pfizer USD 0.87 0.09 Sep/2025
Repligen USD 0.46 0.09 Sep/2025
Revvity USD 1.7 0.52 Dec/2025
Standard Biotools USD -0.08 0.04 Sep/2025
Thermo Fisher Scientific USD 6.57 0.78 Dec/2025
Waters USD 3.4 0.45 Sep/2025
West Pharmaceutical Services USD 1.96 0.12 Sep/2025